Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Clovis Oncology Secures FDA Approval for New Ovarian Cancer Drug
Clovis Oncology Secures FDA Approval for New Ovarian Cancer Drug
Clovis Oncology Secures FDA Approval for New Ovarian Cancer Drug
Submitted by
admin
on December 19, 2016 - 11:51am
Source:
TheStreet.com
News Tags:
Clovis Oncology
FDA
PARP inhibitors
rucaparib
ovarian cancer
Rubraca
Headline:
Clovis Oncology Secures FDA Approval for New Ovarian Cancer Drug
Do Not Allow Advertisers to Use My Personal information
